chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Blood pressure measurement, Chills, Diarrhoea
Clinical narrative: High blood pressure; Felt bad; Weakness; Upset stomach; Diarrhea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure), MALAISE (Felt bad), ASTHENIA (Weakness), ABDOMINAL DISCOMFORT (Upset stomach) and DIARRHOEA (Diarrhea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced HYPERTENSION (High blood pressure), MALAISE (Felt bad), ASTHENIA (Weakness), ABDOMINAL DISCOMFORT (Upset stomach), DIARRHOEA (Diarrhea) and CHILLS (Chills). On 26-Jan-2021, MALAISE (Felt bad), ASTHENIA (Weakness), ABDOMINAL DISCOMFORT (Upset stomach), DIARRHOEA (Diarrhea) and CHILLS (Chills) had resolved. At the time of the report, HYPERTENSION (High blood pressure) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Blood pressure measurement: 200/100 (High) high blood pressure of 200 over 100. On an unknown date, Blood pressure measurement: 134/95 (High) blood pressure down to 134/95.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Malaise
Clinical narrative: High blood pressure; Felt bad; Weakness; Upset stomach; Diarrhea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure), MALAISE (Felt bad), ASTHENIA (Weakness), ABDOMINAL DISCOMFORT (Upset stomach) and DIARRHOEA (Diarrhea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced HYPERTENSION (High blood pressure), MALAISE (Felt bad), ASTHENIA (Weakness), ABDOMINAL DISCOMFORT (Upset stomach), DIARRHOEA (Diarrhea) and CHILLS (Chills). On 26-Jan-2021, MALAISE (Felt bad), ASTHENIA (Weakness), ABDOMINAL DISCOMFORT (Upset stomach), DIARRHOEA (Diarrhea) and CHILLS (Chills) had resolved. At the time of the report, HYPERTENSION (High blood pressure) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, Blood pressure measurement: 200/100 (High) high blood pressure of 200 over 100. On an unknown date, Blood pressure measurement: 134/95 (High) blood pressure down to 134/95.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Swelling on her face and chin.; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swelling on her face and chin.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Swelling on her face and chin.). At the time of the report, SWELLING FACE (Swelling on her face and chin.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Peripheral swelling
Clinical narrative: swollen arm; warm arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm) and INJECTION SITE WARMTH (warm arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced PERIPHERAL SWELLING (swollen arm) and INJECTION SITE WARMTH (warm arm). At the time of the report, PERIPHERAL SWELLING (swollen arm) and INJECTION SITE WARMTH (warm arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Bradykinesia, Chills, Fatigue, Hyperhidrosis, Influenza like illness
Clinical narrative: Not feeling well; completely drenched; moving slow; had flu-like symptoms all night; fever; shivering; Feeling exhausted; chills; nausea; Had a swollen gland and hard; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), FATIGUE (Feeling exhausted), BRADYKINESIA (moving slow), INFLUENZA LIKE ILLNESS (had flu-like symptoms all night) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced MALAISE (Not feeling well), FATIGUE (Feeling exhausted), BRADYKINESIA (moving slow), INFLUENZA LIKE ILLNESS (had flu-like symptoms all night), PYREXIA (fever), CHILLS (shivering), HYPERHIDROSIS (completely drenched), CHILLS (chills), NAUSEA (nausea) and LYMPHADENOPATHY (Had a swollen gland and hard). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (Not feeling well), FATIGUE (Feeling exhausted), BRADYKINESIA (moving slow), INFLUENZA LIKE ILLNESS (had flu-like symptoms all night), PYREXIA (fever), CHILLS (shivering), HYPERHIDROSIS (completely drenched), CHILLS (chills), NAUSEA (nausea) and LYMPHADENOPATHY (Had a swollen gland and hard) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Malaise, Nausea, Pyrexia
Clinical narrative: Not feeling well; completely drenched; moving slow; had flu-like symptoms all night; fever; shivering; Feeling exhausted; chills; nausea; Had a swollen gland and hard; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well), FATIGUE (Feeling exhausted), BRADYKINESIA (moving slow), INFLUENZA LIKE ILLNESS (had flu-like symptoms all night) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced MALAISE (Not feeling well), FATIGUE (Feeling exhausted), BRADYKINESIA (moving slow), INFLUENZA LIKE ILLNESS (had flu-like symptoms all night), PYREXIA (fever), CHILLS (shivering), HYPERHIDROSIS (completely drenched), CHILLS (chills), NAUSEA (nausea) and LYMPHADENOPATHY (Had a swollen gland and hard). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (Not feeling well), FATIGUE (Feeling exhausted), BRADYKINESIA (moving slow), INFLUENZA LIKE ILLNESS (had flu-like symptoms all night), PYREXIA (fever), CHILLS (shivering), HYPERHIDROSIS (completely drenched), CHILLS (chills), NAUSEA (nausea) and LYMPHADENOPATHY (Had a swollen gland and hard) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: positive COVID-19 after first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of SARS-COV-2 TEST POSITIVE (positive COVID-19 after first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (positive COVID-19 after first dose). At the time of the report, SARS-COV-2 TEST POSITIVE (positive COVID-19 after first dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Rash
Clinical narrative: Rash is on his neck and belly concentrated on the right side and both of his legs; lowgrade temperature of 100 degrees F; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Rash is on his neck and belly concentrated on the right side and both of his legs), PYREXIA (lowgrade temperature of 100 degrees F) and CHILLS (Chills) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included SIMVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), LISINOPRIL, MELATONIN, COLECALCIFEROL (VITAMIN D3 1000), HCTZ and FERROUS SULFATE for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PYREXIA (lowgrade temperature of 100 degrees F) and CHILLS (Chills). On 16-Jan-2021, the patient experienced RASH (Rash is on his neck and belly concentrated on the right side and both of his legs). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and TRIAMCINOLONE for Rash, at an unspecified dose and frequency. On 14-Jan-2021, PYREXIA (lowgrade temperature of 100 degrees F) and CHILLS (Chills) had resolved. At the time of the report, RASH (Rash is on his neck and belly concentrated on the right side and both of his legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Positive COVID test; Bad headache; Fever of 101.4; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive COVID test), HEADACHE (Bad headache) and PYREXIA (Fever of 101.4) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Positive COVID test), HEADACHE (Bad headache) and PYREXIA (Fever of 101.4). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive COVID test), HEADACHE (Bad headache) and PYREXIA (Fever of 101.4) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, Pyrexia: fever of 101.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were Blood pressure medications. Treatment details was not reported by the reporter.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dehydration, Oral discomfort, Pain in extremity, Pyrexia
Clinical narrative: Arms hurt and  legs ached; Terrible cough; Burning mouth; A little dehydrated; Fever of 100.9 (degrees Fahrenheit); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arms hurt and  legs ached), COUGH (Terrible cough), ORAL DISCOMFORT (Burning mouth), DEHYDRATION (A little dehydrated) and PYREXIA (Fever of 100.9 (degrees Fahrenheit)) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Flu in 2020.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arms hurt and  legs ached), COUGH (Terrible cough), ORAL DISCOMFORT (Burning mouth), DEHYDRATION (A little dehydrated) and PYREXIA (Fever of 100.9 (degrees Fahrenheit)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arms hurt and  legs ached), COUGH (Terrible cough), ORAL DISCOMFORT (Burning mouth), DEHYDRATION (A little dehydrated) and PYREXIA (Fever of 100.9 (degrees Fahrenheit)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Contusion, Myalgia
Clinical narrative: Hard time due to chills; Bruise at site of injection; Arm soreness; This spontaneous case was reported by an other and describes the occurrence of CONTUSION (Bruise at site of injection), MYALGIA (Arm soreness) and CHILLS (Hard time due to chills) in a 70-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced CONTUSION (Bruise at site of injection) and MYALGIA (Arm soreness). On 01-Feb-2021, the patient experienced CHILLS (Hard time due to chills). At the time of the report, CONTUSION (Bruise at site of injection), MYALGIA (Arm soreness) and CHILLS (Hard time due to chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pruritus, Vaccination site reaction
Clinical narrative: skin reaction that has grown rather large 4in by 3in still hanging around; itching mildly; has some heat; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (skin reaction that has grown rather large 4in by 3in still hanging around), PRURITUS (itching mildly) and FEELING HOT (has some heat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Depression and Migraine. Concomitant products included VORTIOXETINE HYDROBROMIDE (TRINTELLIX), BREXPIPRAZOLE (REXULTI) and CARVEDILOL for Depression, GABAPENTIN and RIZATRIPTAN for Headache, ALPRAZOLAM (XANAX) for Sleeplessness, BUTALBITAL, CAFFEINE, PARACETAMOL (BUTALBIT/APAP/CAFFEINE PLUS), AMITRIPTYLINE and TOPIRAMATE for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (skin reaction that has grown rather large 4in by 3in still hanging around), PRURITUS (itching mildly) and FEELING HOT (has some heat). At the time of the report, VACCINATION SITE REACTION (skin reaction that has grown rather large 4in by 3in still hanging around), PRURITUS (itching mildly) and FEELING HOT (has some heat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included ice on the itching site.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding
Clinical narrative: breastfeeding and 1st dose and 2nd dose Moderna's COVID-19 vaccine received; This spontaneous case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding and 1st dose and 2nd dose Moderna's COVID-19 vaccine received) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A and 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hashimoto's disease, MULTIVITAMINS & MINERALS PLUS LUTEIN for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 04-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding and 1st dose and 2nd dose Moderna's COVID-19 vaccine received). At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (breastfeeding and 1st dose and 2nd dose Moderna's COVID-19 vaccine received) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details was not reported by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Vaccination site pain
Clinical narrative: Toes started to itch; Was red; Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Toes started to itch), ERYTHEMA (Was red) and VACCINATION SITE PAIN (Soreness at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol and Shellfish allergy.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site). On 19-Jan-2021, the patient experienced PRURITUS (Toes started to itch) and ERYTHEMA (Was red). At the time of the report, PRURITUS (Toes started to itch), ERYTHEMA (Was red) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included high cholesterol medications. Treatment details was not reported by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Headache
Clinical narrative: Diarrhea; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and HEADACHE (Slight headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced DIARRHOEA (Diarrhea) and HEADACHE (Slight headache). At the time of the report, DIARRHOEA (Diarrhea) and HEADACHE (Slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: U
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: dizziness, like vertigo; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (dizziness, like vertigo) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (dizziness, like vertigo). At the time of the report, VERTIGO (dizziness, like vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash
Clinical narrative: a red area on her arm; a rash, it was 7 inches long and now it is dissipating; had her arm a little sore for 2-3 days; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (had her arm a little sore for 2-3 days), VACCINATION SITE ERYTHEMA (a red area on her arm) and VACCINATION SITE RASH (a rash, it was 7 inches long and now it is dissipating) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PAIN (had her arm a little sore for 2-3 days). On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (a red area on her arm) and VACCINATION SITE RASH (a rash, it was 7 inches long and now it is dissipating). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. On 21-Jan-2021, VACCINATION SITE PAIN (had her arm a little sore for 2-3 days) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (a red area on her arm) and VACCINATION SITE RASH (a rash, it was 7 inches long and now it is dissipating) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling, Vaccination site urticaria
Clinical narrative: vaccination site rash; vaccination site pruritus; Vaccination site swelling; vaccination site urticaria; flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (vaccination site rash), VACCINATION SITE PRURITUS (vaccination site pruritus), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE URTICARIA (vaccination site urticaria) and INFLUENZA LIKE ILLNESS (flu-like symptoms) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). On 31-Jan-2021, the patient experienced VACCINATION SITE RASH (vaccination site rash), VACCINATION SITE PRURITUS (vaccination site pruritus), VACCINATION SITE SWELLING (Vaccination site swelling) and VACCINATION SITE URTICARIA (vaccination site urticaria). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Injection site rash, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (vaccination site rash), VACCINATION SITE PRURITUS (vaccination site pruritus), VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE URTICARIA (vaccination site urticaria) and INFLUENZA LIKE ILLNESS (flu-like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Myalgia, Pruritus, Vaccination site hypersensitivity
Clinical narrative: itch; sore arm; Vaccination site warmth; hypersensitivity, redness and itch again; hypersensitivity, redness and itch again; hypersensitivity, redness and itch again; vaccination site hypersensitivity; REDNESS; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (REDNESS), PRURITUS (itch), MYALGIA (sore arm), INJECTION SITE WARMTH (warm to touch) and ERYTHEMA (hypersensitivity, redness and itch again) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ERYTHEMA (REDNESS). On 29-Jan-2021, the patient experienced PRURITUS (itch), MYALGIA (sore arm), INJECTION SITE WARMTH (warm to touch), ERYTHEMA (hypersensitivity, redness and itch again) and PRURITUS (hypersensitivity, redness and itch again). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 23-Jan-2021 to 26-Jan-2021 for Adverse event, at an unspecified dose and frequency. On 26-Jan-2021, ERYTHEMA (REDNESS) had resolved. At the time of the report, PRURITUS (itch), MYALGIA (sore arm), INJECTION SITE WARMTH (warm to touch), ERYTHEMA (hypersensitivity, redness and itch again) and PRURITUS (hypersensitivity, redness and itch again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: itch; sore arm; Vaccination site warmth; hypersensitivity, redness and itch again; hypersensitivity, redness and itch again; hypersensitivity, redness and itch again; vaccination site hypersensitivity; REDNESS; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (REDNESS), PRURITUS (itch), MYALGIA (sore arm), INJECTION SITE WARMTH (warm to touch) and ERYTHEMA (hypersensitivity, redness and itch again) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ERYTHEMA (REDNESS). On 29-Jan-2021, the patient experienced PRURITUS (itch), MYALGIA (sore arm), INJECTION SITE WARMTH (warm to touch), ERYTHEMA (hypersensitivity, redness and itch again) and PRURITUS (hypersensitivity, redness and itch again). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 23-Jan-2021 to 26-Jan-2021 for Adverse event, at an unspecified dose and frequency. On 26-Jan-2021, ERYTHEMA (REDNESS) had resolved. At the time of the report, PRURITUS (itch), MYALGIA (sore arm), INJECTION SITE WARMTH (warm to touch), ERYTHEMA (hypersensitivity, redness and itch again) and PRURITUS (hypersensitivity, redness and itch again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Itching on the Injection Site; redness on the injection site; Rash with bumps on the Injection Site; Swelling on the Injection Site; Tenderness Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash with bumps on the Injection Site) and VACCINATION SITE SWELLING (Swelling on the Injection Site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash with bumps on the Injection Site) and VACCINATION SITE SWELLING (Swelling on the Injection Site). The patient was treated with HYDROCORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (Rash with bumps on the Injection Site) and VACCINATION SITE SWELLING (Swelling on the Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Vaccination site swelling; Vaccination site erythema; Heat at the injection site; itching at the injection site; Headache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE WARMTH (Heat at the injection site), VACCINATION SITE PRURITUS (itching at the injection site) and HEADACHE (Headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, ATORVASTATIN CALCIUM (LIPITOR) and VITAMINS NOS for an unknown indication.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE WARMTH (Heat at the injection site), VACCINATION SITE PRURITUS (itching at the injection site) and HEADACHE (Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPRIN) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (Vaccination site swelling), VACCINATION SITE ERYTHEMA (Vaccination site erythema), VACCINATION SITE WARMTH (Heat at the injection site), VACCINATION SITE PRURITUS (itching at the injection site) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information: anti-inflammatories and ice
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site warmth
Clinical narrative: Vaccination site warmth; Vaccination site pain; This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE PAIN (arm sore) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (arm sore). At the time of the report, INJECTION SITE PAIN (arm sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not reported  Treatment information was not provided
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: itchiness at the injection site; Redness at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Sensitive skin.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchiness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications product use was not reported.  Treatment information included cold compress.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity
Clinical narrative: Arm Pain; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills) and FATIGUE (Fatigue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills) and FATIGUE (Fatigue). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency. On 07-Jan-2021, PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  The patient had received their second of two planned doses of mRNA-1273 on 02-FEB2-021, in the left upper arm.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Lymphadenopathy, Ultrasound chest, Vaccination site pain
Clinical narrative: Lymph node on left neck side which has kind of moved up for almost 2-3 weeks.; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph node on left neck side which has kind of moved up for almost 2-3 weeks.) and VACCINATION SITE PAIN (Pain at injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced LYMPHADENOPATHY (Lymph node on left neck side which has kind of moved up for almost 2-3 weeks.) and VACCINATION SITE PAIN (Pain at injection site). The patient was treated with PARACETAMOL (TYLENOL) on 14-Jan-2021 for Injection site pain, at a dose of 1 dosage form. At the time of the report, LYMPHADENOPATHY (Lymph node on left neck side which has kind of moved up for almost 2-3 weeks.) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Chest X-ray: normal (normal) everything looks fine. In January 2021, Ultrasound chest: normal (normal) everything looks fine.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  It was reported that the lab tests performed looked fine and the results for biopsy was pending at the time of report.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: top part of her arm was very red, a little circle and then larger; sort of warm; sort of itchy; a little circle and then larger; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (top part of her arm was very red, a little circle and then larger) and VACCINATION SITE WARMTH (sort of warm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced ERYTHEMA (top part of her arm was very red, a little circle and then larger) and VACCINATION SITE WARMTH (sort of warm). On 01-Feb-2021, ERYTHEMA (top part of her arm was very red, a little circle and then larger) and VACCINATION SITE WARMTH (sort of warm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Patient applied unspecified antihistamine cream as treatment.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Developed rash, warm, red, itchy, got a lump near injection; got a lump near injection site; itchy; Developed rash; red; injection site is still sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Developed rash, warm, red, itchy, got a lump near injection), VACCINATION SITE MASS (got a lump near injection site), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (Developed rash) and VACCINATION SITE ERYTHEMA (red) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012LD0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE WARMTH (Developed rash, warm, red, itchy, got a lump near injection), VACCINATION SITE MASS (got a lump near injection site), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (Developed rash), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (injection site is still sore). At the time of the report, VACCINATION SITE WARMTH (Developed rash, warm, red, itchy, got a lump near injection), VACCINATION SITE MASS (got a lump near injection site), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (Developed rash) and VACCINATION SITE ERYTHEMA (red) outcome was unknown and VACCINATION SITE PAIN (injection site is still sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Patient's physician advised to get an ultrasound for the lump developed at the injection site.  Patient did not take any treatment medications for the symptoms.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Developed rash, warm, red, itchy, got a lump near injection; got a lump near injection site; itchy; Developed rash; red; injection site is still sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Developed rash, warm, red, itchy, got a lump near injection), VACCINATION SITE MASS (got a lump near injection site), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (Developed rash) and VACCINATION SITE ERYTHEMA (red) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012LD0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE WARMTH (Developed rash, warm, red, itchy, got a lump near injection), VACCINATION SITE MASS (got a lump near injection site), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (Developed rash), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (injection site is still sore). At the time of the report, VACCINATION SITE WARMTH (Developed rash, warm, red, itchy, got a lump near injection), VACCINATION SITE MASS (got a lump near injection site), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE RASH (Developed rash) and VACCINATION SITE ERYTHEMA (red) outcome was unknown and VACCINATION SITE PAIN (injection site is still sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Patient's physician advised to get an ultrasound for the lump developed at the injection site.  Patient did not take any treatment medications for the symptoms.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pain in extremity
Clinical narrative: legs started to hurt; she is tired (kind of flu tired); chills; she is feeling like vomit; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (legs started to hurt), FATIGUE (she is tired (kind of flu tired)), CHILLS (chills) and NAUSEA (she is feeling like vomit) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included Heart transplant.    On 02-Feb-2021 at 12:40 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (legs started to hurt), FATIGUE (she is tired (kind of flu tired)), CHILLS (chills) and NAUSEA (she is feeling like vomit). The patient was treated with PARACETAMOL (TYLENOL) on 02-Feb-2021 for Adverse reaction, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (legs started to hurt), FATIGUE (she is tired (kind of flu tired)), CHILLS (chills) and NAUSEA (she is feeling like vomit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medication included unspecified rejection medicine taking for heart transplant.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Fatigue, Feeling abnormal, Headache
Clinical narrative: left arm and chin were so itchy; left arm and chin were so itchy and was all red; left arm and chin were so itchy and was all red and bumps; dizzy spells; headache; pharmacist pricked but then had to take it out and do it again so patient was pricked twice; did not feel like herself and had a weird feeling; very fatigued; This spontaneous case was reported by a consumer and describes the occurrence of INJURY ASSOCIATED WITH DEVICE (pharmacist pricked but then had to take it out and do it again so patient was pricked twice), FEELING ABNORMAL (did not feel like herself and had a weird feeling), DIZZINESS (dizzy spells), PRURITUS (left arm and chin were so itchy) and ERYTHEMA (left arm and chin were so itchy and was all red) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), PROGESTERONE, LORAZEPAM and FISH OIL for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INJURY ASSOCIATED WITH DEVICE (pharmacist pricked but then had to take it out and do it again so patient was pricked twice), FEELING ABNORMAL (did not feel like herself and had a weird feeling) and FATIGUE (very fatigued). On 30-Jan-2021, the patient experienced DIZZINESS (dizzy spells) and HEADACHE (headache). On 01-Feb-2021, the patient experienced PRURITUS (left arm and chin were so itchy), ERYTHEMA (left arm and chin were so itchy and was all red) and PAPULE (left arm and chin were so itchy and was all red and bumps). The patient was treated with PARACETAMOL (TYLENOL) on 30-Jan-2021 for Headache, at an unspecified dose and frequency and COCONUT OIL on 01-Feb-2021 for Pruritus, at an unspecified dose and frequency. On 23-Jan-2021, INJURY ASSOCIATED WITH DEVICE (pharmacist pricked but then had to take it out and do it again so patient was pricked twice), FEELING ABNORMAL (did not feel like herself and had a weird feeling) and FATIGUE (very fatigued) had resolved. On 31-Jan-2021, DIZZINESS (dizzy spells) and HEADACHE (headache) had resolved. On 02-Feb-2021, PRURITUS (left arm and chin were so itchy) had resolved. At the time of the report, ERYTHEMA (left arm and chin were so itchy and was all red) and PAPULE (left arm and chin were so itchy and was all red and bumps) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.